LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹43.88 | ₹41.11 | ₹46.58 | ₹36.40 | ₹34.63 |
What is the latest Earnings Per Share (EPS) of LINCOLN PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹43.88 |
| Mar2025 | ₹41.11 |
| Mar2024 | ₹46.58 |
| Mar2023 | ₹36.40 |
| Mar2022 | ₹34.63 |
How is Earnings Per Share (EPS) of LINCOLN PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹43.88 | 6.74 | |
| Mar2025 | ₹41.11 | -11.74 | |
| Mar2024 | ₹46.58 | 27.97 | |
| Mar2023 | ₹36.40 | 5.11 | |
| Mar2022 | ₹34.63 | - | |
Compare Earnings Per Share (EPS) of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,100.4 Cr | -2.6% | -13.5% | 2.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -2.6% |
-13.5% |
2.8% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses